Search

Search Constraints

You searched for: Is Part Of ESMO open. Volume 4:Issue 2(2019)

Search Results

2. Benefit from anti-EGFRs in RAS and BRAF wild-type metastatic transverse colon cancer: a clinical and molecular proof of concept study. Issue 2 (8th March 2019)

3. Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectable. Issue 2 (9th May 2019)

6. Cyclin D1 differential activation and its prognostic impact in patients with advanced breast cancer treated with trastuzumab. Issue 2 (12th May 2019)

8. Genomic heterogeneity and efficacy of PI3K pathway inhibitors in patients with gynaecological cancer. Issue 2 (8th March 2019)